Vidac Pharma Holding Overview
- Year Founded
-
2012
- Status
-
Public
- Employees
-
7
- Stock Symbol
-
T9G
- Share Price
-
$0.21
- (As of Friday Closing)
Vidac Pharma Holding General Information
Description
Vidac Pharma Holding PLC is a clinical-stage biopharmaceutical company that focuses on discovering and developing medicines for oncologic and onco-dermatologic diseases. The company's research targets the modification of the tumor microenvironment to inhibit cancer cell growth by selectively affecting metabolic checkpoints in cancer cells without harming normal tissue. Its drug pipeline includes candidates such as VDA-1102 ointment, VDA-1102 IV, and VDA-1275, which are designed to treat conditions like Actinic Keratosis and Cutaneous T-cell Lymphoma.
Contact Information
Website
www.vidacpharma.comCorporate Office
- 20-22 Wenlock Road
- London N1 7GU
- England, United Kingdom
Corporate Office
- 20-22 Wenlock Road
- London N1 7GU
- England, United Kingdom
Vidac Pharma Holding Stock Performance
As of 13-Nov-2026, Vidac Pharma Holding’s stock price is $0.21. Its current market cap is $12.2M with 56.9M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.21 | $0.21 | $0.15 - $1.12 | $12.2M | 56.9M | 7.76K |
Vidac Pharma Holding Financials Summary
As of 30-Jun-2026, Vidac Pharma Holding has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 30,772 | 38,361 | 38,221 | |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (3,164) | (2,533) | (1,685) | (1,596) |
| Net Income | (3,164) | (2,490) | (1,771) | (1,585) |
| Total Assets | 335 | 883 | 2,964 | 152 |
| Total Debt | 452 | 424 | 402 | 181 |
Vidac Pharma Holding Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Vidac Pharma Holding Comparisons
Industry
Financing
Details
Vidac Pharma Holding Competitors (18)
One of Vidac Pharma Holding’s 18 competitors is Gilead, a Formerly VC-backed company based in Foster City, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Gilead | Formerly VC-backed | Foster City, CA | ||||
| Avalyn Pharma | Formerly VC-backed | Boston, MA | ||||
| Amgen | Formerly PE-Backed | Thousand Oaks, CA | ||||
| Ona Therapeutics | Venture Capital-Backed | Barcelona, Spain | ||||
| Merck & Co. | Corporation | Rahway, NJ |
Vidac Pharma Holding Patents
Vidac Pharma Holding Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026190777-A1 | Formulations for delivery of hydrophobic drugs or drugs sensitive to rapid hydrolysis and uses thereof | Pending | 09-Mar-2025 | ||
| AU-2025215741-A1 | Synergistic therapies for treating cancer | Pending | 30-Jan-2024 | ||
| WO-2025163633-A1 | Synergistic therapies for treating cancer | Pending | 30-Jan-2024 | ||
| EP-3735402-A1 | Methods for preparation of jasmonate compounds | Inactive | 07-Jan-2018 | ||
| EP-3735402-A4 | Methods for preparation of jasmonate compounds | Inactive | 07-Jan-2018 | C07D215/32 |
Vidac Pharma Holding Signals
Vidac Pharma Holding ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Vidac Pharma Holding FAQs
-
When was Vidac Pharma Holding founded?
Vidac Pharma Holding was founded in 2012.
-
Where is Vidac Pharma Holding headquartered?
Vidac Pharma Holding is headquartered in London, United Kingdom.
-
What is the size of Vidac Pharma Holding?
Vidac Pharma Holding has 7 total employees.
-
What industry is Vidac Pharma Holding in?
Vidac Pharma Holding’s primary industry is Drug Discovery.
-
Is Vidac Pharma Holding a private or public company?
Vidac Pharma Holding is a Public company.
-
What is Vidac Pharma Holding’s stock symbol?
The ticker symbol for Vidac Pharma Holding is T9G.
-
What is the current stock price of Vidac Pharma Holding?
As of 13-Nov-2026 the stock price of Vidac Pharma Holding is $0.21.
-
What is the current market cap of Vidac Pharma Holding?
The current market capitalization of Vidac Pharma Holding is $12.2M.
-
Who are Vidac Pharma Holding’s competitors?
Gilead, Avalyn Pharma, Amgen, Ona Therapeutics, and Merck & Co. are some of the 18 competitors of Vidac Pharma Holding.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process